Literature DB >> 2948527

Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a).

L J Seman, W C Breckenridge.   

Abstract

A procedure was developed for the dissociation of apolipoprotein (a) (apo (a)) from pure human lipoprotein (a) (Lp(a)) prepared by density gradient ultracentrifugation and gel filtration. Lp(a) was ultracentrifuged through a layer of saline which was adjusted to a density of 1.182 g/mL and contained 30 mM dithiothreitol (50 mM) and phenylmethylsulfonyl fluoride (1.25 mM). Following centrifugation, the lipid and apolipoprotein B (apo B) were recovered as a lipoprotein (Lp(a) B) in the supernatant fraction, while the apo (a) was recovered as a lipid-poor protein pellet. An investigation of the supernatant lipoprotein by electron microscopy and compositional analysis revealed that it was similar in size and composition to low density lipoprotein (LDL) isolated from the same density range and contained apo B100 with an amino acid and carbohydrate composition which was similar to apo B from LDL. Estimates of the apparent molecular weight of the apo (a) varied amongst individuals but was always greater than apo B100 (congruent to 450,000). The amino acid composition of apo (a), which was very distinct from apo B, was characterized by a higher content of serine, threonine, proline, and tyrosine, but lower amounts of isoleucine, phenylalanine, and lysine when compared with apo B of Lp(a) or LDL. The apo (a) contained a much higher proportion of carbohydrate, in particular N-acetylgalactosamine, galactose, and N-acetylneuraminic acid (which were three- to six-fold higher) than the apo B of Lp(a). It is concluded that apo (a) is distinct from other apolipoproteins owing to its low avidity for lipid and the nature of the interaction with apo B. Lp(a) consists of an LDL-like particle with a carbohydrate-rich apo (a) attached to the surface of apo B.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2948527     DOI: 10.1139/o86-133

Source DB:  PubMed          Journal:  Biochem Cell Biol        ISSN: 0829-8211            Impact factor:   3.626


  15 in total

1.  Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Wei Zhang; Lars Berglund
Journal:  Atherosclerosis       Date:  2014-05-10       Impact factor: 5.162

2.  PCSK9 inhibition-mediated reduction in Lp(a) with evolocumab: an analysis of 10 clinical trials and the LDL receptor's role.

Authors:  Frederick J Raal; Robert P Giugliano; Marc S Sabatine; Michael J Koren; Dirk Blom; Nabil G Seidah; Narimon Honarpour; Armando Lira; Allen Xue; Padmaja Chiruvolu; Simon Jackson; Mei Di; Matthew Peach; Ransi Somaratne; Scott M Wasserman; Rob Scott; Evan A Stein
Journal:  J Lipid Res       Date:  2016-04-21       Impact factor: 5.922

3.  Lipoprotein (a): genetic marker for atherosclerosis?

Authors:  W C Breckenridge
Journal:  CMAJ       Date:  1990-07-15       Impact factor: 8.262

4.  Reduction of Lp(a) by different methods of plasma exchange.

Authors:  I Schenck; C Keller; S Hailer; G Wolfram; N Zöllner
Journal:  Klin Wochenschr       Date:  1988-12-15

5.  The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study.

Authors:  Anandita Agarwala; Yashashwi Pokharel; Anum Saeed; Wensheng Sun; Salim S Virani; Vijay Nambi; Chiadi Ndumele; Eyal Shahar; Gerardo Heiss; Eric Boerwinkle; Suma Konety; Ron C Hoogeveen; Christie M Ballantyne
Journal:  Atherosclerosis       Date:  2017-05-12       Impact factor: 5.162

6.  High Lipoprotein(a) Levels are Associated With Long-Term Adverse Outcomes in Acute Myocardial Infarction Patients in High Killip Classes.

Authors:  Jae Yeong Cho; Myung Ho Jeong; Youngkeun Ahn; Young Joon Hong; Hyung Wook Park; Nam Sik Yoon; Hyun Ju Yoon; Kye Hun Kim; Ju Han Kim; Jeong Gwan Cho; Jong Chun Park; Jung Chaee Kang
Journal:  Korean Circ J       Date:  2010-10-31       Impact factor: 3.243

7.  Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a).

Authors:  Margaret R Diffenderfer; Stefania Lamon-Fava; Santica M Marcovina; P Hugh R Barrett; Julian Lel; Gregory G Dolnikowski; Lars Berglund; Ernst J Schaefer
Journal:  Metabolism       Date:  2015-11-06       Impact factor: 8.694

8.  Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.

Authors:  D L Eaton; G M Fless; W J Kohr; J W McLean; Q T Xu; C G Miller; R M Lawn; A M Scanu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

9.  Interaction of apolipoprotein[a] with apolipoproteinB-100 Cys3734 region in lipoprotein[a] is confirmed immunochemically.

Authors:  J Guevara; N V Valentinova; O Garcia; A M Gotto; C Y Yang; S Legal; J Gaubatz; J T Sparrow
Journal:  J Protein Chem       Date:  1996-01

10.  Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a].

Authors:  J Guevara; J Spurlino; A Y Jan; C Y Yang; A Tulinsky; B V Prasad; J W Gaubatz; J D Morrisett
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.